Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roctavian
Marketing
BioMarin’s commercial chief Jeffrey Ajer hits the exit
BioMarin's commercial lead Jeffrey Ajer will leave the company by July.
Ben Adams
Jan 12, 2024 10:28am
JPM24: New BioMarin CEO Hardy makes his priorities clear
Jan 10, 2024 11:29am
Activist investor Elliott takes $1B stake in BioMarin: report
Nov 8, 2023 8:25am
BioMarin's hemophilia gene therapy may win over Europe: analysts
Jun 14, 2023 11:20am
'The Top Line': AI and machine learning, plus the headlines
Mar 10, 2023 6:00am
BioMarin's Roctavian hit with 3-month FDA delay
Mar 7, 2023 11:41am